In 2005, three spectacular data security breaches focused public attention on the vast databases of personal information held by data traders such as ChoicePoint and LexisNexis, and the vulnerability of that data.
UBS trader Kweku Adoboli allegedly made unauthorized trades that cost the Swiss investment bank billions.
Financial traders are more uncooperative than psychopaths, and also that they have a greater tendency for lying and risk-taking, according to a new study from a Swiss University. The new research about financial traders and their personalities may shed some light [...]
As authorities investigate an alleged rogue trader at UBS, British regulators are examining multiple cases of possible improper or unauthorized trading at banks operating in London, according to people familiar with the matter.
The current maelstrom in the financial world is not a discrete event. Our attitude in general about risk, especially low-probability, hidden risk, is similar to that of the man who sleeps on the railroad tracks but does not know about the existence of trains. Much of the time he can sleep there undisturbed. But he need only be wrong once in his timing to suffer catastrophe.
NanoPass Technologies Ltd. ("NanoPass"), a pioneer in intradermal (into-the-skin) delivery solutions for vaccines, announced that it has recently entered into a license agreement for the MicronJet™, its microneedle intradermal delivery device, with Circassia Ltd. (Oxford, UK) ("Circassia"), a specialty biopharmaceutical company focused on allergy and autoimmune diseases.
British regulators want to know why the Swiss bank failed to detect the huge losses that a trader was piling up.
Sept 17 - London-based UBS trader is charged with fraud and false accounting as his father asks the world not to judge him ahead of his trial.
NanoPass Technologies Ltd. ("NanoPass"), a pioneer in intradermal (into-the-skin) delivery solutions for vaccines, announced that it has recently entered into a license agreement for the MicronJet™, its microneedle intradermal delivery device, with Circassia Ltd. (Oxford, UK) ("Circassia"), a specialty biopharmaceutical company focused on allergy and autoimmune diseases.
